By Alex Wittenberg ( October 3, 2023, 11:34 AM EDT) -- Biotechnology company Zymergen Inc. on Tuesday filed for Chapter 11 protection in Delaware with both assets and debts of $100 million to $500 million, saying it's seeking an asset sale and aiming to collate securities claims tied to a sharp drop in its share price following a 2021 initial public offering....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.